Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 83033 refers to a laboratory test specifically designed to identify fetal hemoglobin, also known as hemoglobin F (HbF), in various biological samples such as gastric or stool specimens and amniotic fluid. Hemoglobin is a crucial protein found in red blood cells (RBCs) that is responsible for transporting oxygen throughout the body. Fetal hemoglobin differs from adult hemoglobin in that it has a higher affinity for oxygen, which is essential for the developing fetus to efficiently extract oxygen from the maternal blood supply. Hemoglobin F is typically present during fetal development, beginning around 10 weeks of gestation, and continues to be produced for approximately six months after birth. The qualitative test for hemoglobin F is particularly useful in clinical scenarios where there is a need to ascertain the source of gastrointestinal bleeding in infants, distinguishing between maternal and infant sources. Additionally, this qualitative testing may be performed alongside other tests, such as those for alpha-fetoprotein (AFP) and acetylcholinesterase, to further investigate elevated AFP levels in amniotic fluid, thereby providing a comprehensive assessment of fetal health and development.
© Copyright 2026 Coding Ahead. All rights reserved.
The qualitative test for fetal hemoglobin (HbF) is indicated in several clinical scenarios, particularly when there is a need to evaluate gastrointestinal bleeding in infants. The following conditions may warrant the performance of this test:
The procedure for conducting the qualitative test for fetal hemoglobin involves several key steps, which are outlined below:
Post-procedure care for the qualitative fetal hemoglobin test primarily involves monitoring the infant for any signs of gastrointestinal bleeding or other complications. If the test is performed on amniotic fluid, the healthcare provider may discuss the implications of the results with the patient, including any necessary follow-up testing or interventions. It is important for healthcare professionals to ensure that parents or guardians are informed about the results and any further steps that may be required based on the findings. Additionally, documentation of the test results and any subsequent actions taken should be maintained in the patient's medical record for continuity of care.
| Short Descr | HEMOGLOBIN FTL F ASSAY QUAL | Medium Descr | HEMOGLOBIN F FETAL QUALITATIVE | Long Descr | Hemoglobin; F (fetal), qualitative | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2023-01-01 | Note | Short description changed. |
| 2011-01-01 | Changed | Short description changed. |
| 2001-01-01 | Changed | Code description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.